Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06042205 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

TISSIUM™ Atraumatic Hernia Repair System (TAHRS) Pilot Study

StatusActive, Not Recruiting
PhaseNot applicable
SponsorTissium
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 16, 2025 (before its estimated July 4, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 100 to confirmed 78
    • Primary and study completion dates: Jun 28, 2026 to Jul 4, 2026
    • Site details revised at 5 of 5 sites
    v9
  2. Enrollment target: 60 to 100
    • Primary and study completion dates: Mar 28, 2025 to Jun 28, 2026
    • Study sites: 4 to 5
    v8
  3. Enrollment target: 35 to 60v7
  4. Study sites: 3 to 4
    • Interventions: TISSIUM™ Adhesive Hernia Repair System (TAHRS) (Device) to TISSIUM™ Atraumatic Hernia Repair System (TAHRS) (Device)
    • Study title revised
    v6
  5. Trial status: Active, Not Recruiting to Recruitingv5 Show 4 more changesShow less
    • Enrollment target: 12 to 35
    • Primary and study completion dates: Dec 27, 2024 to Mar 28, 2025
    • Eligibility criteria revised
    • Site details revised at 3 of 3 sites
Show 3 earlier versionsHide 3 earlier versions
  1. Study sites: 2 to 3v4
  2. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 2 of 2 sites
    v3
  3. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Tissium
3 trials monitored
See all monitored trials
The purpose of this study is to capture preliminary clinical safety and performance on the TAHRS
Trial Details
NCT Number NCT06042205
Lead Sponsor Tissium
Conditions
(from sponsor)		 Hernia
Related terms Hernia
Enrollment 78 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov